<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>同写意 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-26T20:31:06+08:00</updated>
  <subtitle>一个以新药创制为核心，汇集国内一流研发精英的大型交流与价值分享平台。“同筑技术人生路，写意中国新药魂”是同写意的初衷与愿景。秉承汇集“一线、一流”，讲求“实用、实在、时效”的原则</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>写意报告 | 王印祥：基于KRAS通路的抗肿瘤药物开发</title>
    <updated>2020-11-26T19:07:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/JAusN4zzwirOpyRbsYQd8w</id>
    <link href="https://mp.weixin.qq.com/s/JAusN4zzwirOpyRbsYQd8w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>山海写意之夜：山海曾经神仙书，写意搭起英雄台</title>
    <updated>2020-11-26T19:07:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/0a20ot_ccsnMhBOnUEMKSg</id>
    <link href="https://mp.weixin.qq.com/s/0a20ot_ccsnMhBOnUEMKSg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>关注杜︱儿科孤儿药仍是热点：谈Oxlumo的获批</title>
    <updated>2020-11-26T19:07:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/MfFBWRMNNrUPrC9BfEpIAQ</id>
    <link href="https://mp.weixin.qq.com/s/MfFBWRMNNrUPrC9BfEpIAQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨亚盛医药启动首个欧洲临床试验</title>
    <updated>2020-11-26T19:07:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/Voxb26jynghPxBnnDLM41w</id>
    <link href="https://mp.weixin.qq.com/s/Voxb26jynghPxBnnDLM41w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Claudin 18.2靶点竞争格局和新机会：CAR-T、双抗、ADC、CARVac</title>
    <updated>2020-11-26T19:07:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/IS3Yg6RZKczKvARe5EIztg</id>
    <link href="https://mp.weixin.qq.com/s/IS3Yg6RZKczKvARe5EIztg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>同写意 | 药明直播间：病理学家如何推动医疗器械研发加速</title>
    <updated>2020-11-26T19:07:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/xf89_UjR2Vt0cieABqbI4Q</id>
    <link href="https://mp.weixin.qq.com/s/xf89_UjR2Vt0cieABqbI4Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>关注杜︱一款新儿童孤儿药的诞生和又一张优先评审券的授予</title>
    <updated>2020-11-25T18:41:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/xd9-K7Tcl0if20PlDtqATg</id>
    <link href="https://mp.weixin.qq.com/s/xd9-K7Tcl0if20PlDtqATg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新药研发，这样定位生物药靶点又快又准！</title>
    <updated>2020-11-25T18:41:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/DngpqdloPTEVG7xj7YpGyQ</id>
    <link href="https://mp.weixin.qq.com/s/DngpqdloPTEVG7xj7YpGyQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>同写意 | 药明直播间：创新药中美双报CMC策略分享</title>
    <updated>2020-11-25T18:41:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/nc9mCCQGJneal638g0Wb6Q</id>
    <link href="https://mp.weixin.qq.com/s/nc9mCCQGJneal638g0Wb6Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药品附条件批准，只为无法继续等待的患者</title>
    <updated>2020-11-24T18:55:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/oXtf7OwZk7Cpt3EIXqvX9w</id>
    <link href="https://mp.weixin.qq.com/s/oXtf7OwZk7Cpt3EIXqvX9w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>会员动态 | 百奥赛图与君实生物达成关于RenMab小鼠授权使用的合作</title>
    <updated>2020-11-24T18:55:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/5nKgf1wjJUOezcYfcLA45A</id>
    <link href="https://mp.weixin.qq.com/s/5nKgf1wjJUOezcYfcLA45A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨加科思CMO王宜博士成为美国胰腺癌领域的10位精英医生之一</title>
    <updated>2020-11-24T18:55:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/YSonVI4S8Jimsw7HMUaExA</id>
    <link href="https://mp.weixin.qq.com/s/YSonVI4S8Jimsw7HMUaExA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨亚盛医药Bcl-2抑制剂APG-2575连获两项中国 Ib/ II期临床试验许可</title>
    <updated>2020-11-24T18:55:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/i0lAsvpQrWVk1iJtg1BWsA</id>
    <link href="https://mp.weixin.qq.com/s/i0lAsvpQrWVk1iJtg1BWsA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创新重构医疗产业：理解趋势，并成为趋势的一部分</title>
    <updated>2020-11-23T14:41:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/5GoZaLDvX5zuiz1Sgl9L1w</id>
    <link href="https://mp.weixin.qq.com/s/5GoZaLDvX5zuiz1Sgl9L1w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>会员动态 | 英派药业包骏：从BD领袖到CEO</title>
    <updated>2020-11-23T14:41:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/AhKhZKHWGAbQM1iNzXzHaQ</id>
    <link href="https://mp.weixin.qq.com/s/AhKhZKHWGAbQM1iNzXzHaQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>同写意 | 药明直播间：医疗器械局部组织反应的生物相容性试验</title>
    <updated>2020-11-23T14:41:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/ygqaf_ieDmVCyKH2Qj3DMA</id>
    <link href="https://mp.weixin.qq.com/s/ygqaf_ieDmVCyKH2Qj3DMA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>同写意 | 药明直播间：创新药中美双报CMC策略分享</title>
    <updated>2020-11-23T14:41:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/QlrQjg1DaYW8X7ft_-awFQ</id>
    <link href="https://mp.weixin.qq.com/s/QlrQjg1DaYW8X7ft_-awFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意访谈︱沈月雷：抗体新分子发现与药物创新如何突破</title>
    <updated>2020-11-22T16:32:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/VSxbhk4eDB0jwjzHbrPkQA</id>
    <link href="https://mp.weixin.qq.com/s/VSxbhk4eDB0jwjzHbrPkQA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>关注杜︱又一项新冠肺炎联合疗法获得FDA的EUA批准</title>
    <updated>2020-11-22T16:32:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/-ddTvDXehRVJqv_Vn9YnTw</id>
    <link href="https://mp.weixin.qq.com/s/-ddTvDXehRVJqv_Vn9YnTw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>会员机构︱阿诺医药CEO路杨先生：创新和差异化并举，将癌症变成一种非致命疾病！</title>
    <updated>2020-11-22T16:32:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/rwKyWZf6bceJurNccSt2_w</id>
    <link href="https://mp.weixin.qq.com/s/rwKyWZf6bceJurNccSt2_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>